Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus (albumin-bound) + ADCs in Advanced Solid Tumors
NCT07241936Phase 2Recruiting
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology
- Start
- Nov 2025
- Primary completion
- Oct 2027
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-sirolimus in solid tumor (advanced stage), sponsored by CSPC ZhongQi Pharmaceutical Technology. Started Nov 2025; status: recruiting.
02
Drugs
nab-sirolimus
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT07241936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07241936.